Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 12:07 save search
PTC Therapeutics Provides Update on R&D Pipeline and Commercial Progress at 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-11 (Crawled : 12:07) - prnewswire.com
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: -1.81%
H: 2.19%
C: -0.14%
j.p. morgan healthcare conference commercialization
COVID-19 Origin and Spread Linked to PLA Hospital and Wuhan Metro System Line 2 by Physician-Scientist Dr. Steven Quay
Published: 2021-01-08 (Crawled : 12:07) - prnewswire.com
ATOS | $1.415 3.28% 3.18% 1M
|
Health Technology
|
| O: 2.21%
H: 1.02%
C: -1.13%
covid
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
granted grant nasdaq
Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -0.22%
H: 1.56%
C: -1.85%
granted grant nasdaq
Spero Therapeutics to Provide Business Update and Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Published: 2020-07-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -1.08%
H: 3.78%
C: 2.61%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-07-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
| Email alert
Add to watchlist
granted grant nasdaq
Spero Therapeutics Announces Second Quarter 2020 Operating Results and Provides Business Update
Published: 2020-08-06 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 0.32%
H: 6.72%
C: 1.96%
results
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
Published: 2020-08-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 4.76%
H: 2.5%
C: -1.27%
fda fda acceptance application therapeutics
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Published: 2020-09-08 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 3.35%
H: 54.43%
C: 41.14%
positive results phase 3 trial topline injection infections
Spero Therapeutics Announces Proposed Public Offering
Published: 2020-09-09 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -3.87%
H: 0.65%
C: -9.59%
offering therapeutics publication
Spero Therapeutics Announces Pricing of Securities Offering
Published: 2020-09-11 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -10.57%
H: 4.07%
C: -0.35%
offering therapeutics
Spero Therapeutics to Present at Investor Conferences in September
Published: 2020-09-15 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.91%
H: 2.46%
C: -1.48%
conference presentation therapeutics
Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
Published: 2020-09-24 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -0.64%
H: 4.16%
C: 0.21%
treatment injection infections
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-09-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.88%
H: 4.99%
C: 2.46%
granted grant nasdaq
Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
Published: 2020-10-16 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: -0.38%
H: 2.08%
C: 0.23%
program
Spero Therapeutics to Provide Business Update and Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Published: 2020-10-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.97%
H: 1.63%
C: -0.37%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-11-03 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 2.06%
H: 7.33%
C: 5.83%
granted grant nasdaq
Spero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update
Published: 2020-11-05 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 0.07%
H: 1.94%
C: -1.58%
results
Spero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020
Published: 2020-11-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.405 0.36% 0.36% 290K
|
Health Technology
|
| O: 1.02%
H: 1.78%
C: -1.95%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.